Results 91 to 100 of about 132,880 (138)

All for one or one for all! [PDF]

REC Interv Cardiol
Camm AJ.
europepmc   +1 more source

[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19]. [PDF]

Rev Esp Quimioter, 2021
Barberán J, Barberán LC, de la Cuerda A.   +2 more
europepmc   +1 more source

Interacciones Fármaco-Gén en Cáncer Oro-Digestivo mediante Inhibidores de Histona Demetilasas

Introduction: Histone demethylase inhibitors (HDMIs) target histone demethylase enzymes, which play a key role in regulating gene expression. Quantum machine learning, particularly Variational Quantum Classifiers (VQCs), offers potential advantages by ...
Ardila, Carlos M., Ayyachamy, Swarnambiga, Pradeep Kumar, Yadalam   +2 more
core   +1 more source

Comparative Analysis of Graph Attention and Graph Convolutional Networks for Predicting Candidate SNP-miRNA-DrugInteractions in Integrated Regulatory Datasets. [PDF]

Acta Odontol Latinoam
Batra V, Yadalam PK, Ardila CM.
europepmc   +1 more source

[Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies]. [PDF]

Rev Neurol, 2023
Paredes-Aragón E, Ruiz-Garcia R, Burneo JG.   +2 more
europepmc   +1 more source

[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [PDF]

Farm Comunitarios
Montero-Gómez A, Sánchez Pozo A.
europepmc   +1 more source

[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy]. [PDF]

Farm Comunitarios
Zaragoza Noguera R, Ballester Montilla A, Somoza Hernández B.   +2 more
europepmc   +1 more source

[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients]. [PDF]

Farm Comunitarios
García Martín DL.
europepmc   +1 more source

[Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol]. [PDF]

Rev Neurol
Arenas-Cabrera C, Cabezudo-García P, Calvo-Medina R, Galeano-Bilbao B, Martínez-Agredano P, Ruiz-Giménez J, Rodríguez-Uranga JJ, Quiroga-Subirana P.   +7 more
europepmc   +1 more source

[Frequency of cutaneous drug reactions in the outpatient dermatology clinic at the National Institute of Cardiology Ignacio Chávez over a ten-year period]. [PDF]

Arch Cardiol Mex
Coria-Vázquez S, Cruz-López S, Espino-Mier K, Lara-Morales SM, Suárez-Velázquez MF, Lacy-Niebla RM.   +5 more
europepmc   +1 more source